查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1982869

全球介入性腫瘤學市場規模、佔有率、趨勢和成長分析報告（2026-2034）

Global Interventional Oncology Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 177 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

介入性腫瘤學市場預計將從 2025 年的 24.6 億美元成長到 2034 年的 46.8 億美元，2026 年至 2034 年的複合年成長率為 7.4%。

隨著微創癌症治療的日益普及，全球介入性腫瘤學市場正在迅速擴張。介入性腫瘤治療方法是指利用消融、栓塞和標靶藥物傳遞等技術，在影像引導下直接標靶治療腫瘤。這些治療方法具有許多優勢，包括縮短恢復時間、降低手術風險、改善患者預後。

多種因素共同推動了這一市場的成長。全球癌症發生率的不斷攀升，使得對有效治療方法的需求日益成長。此外，醫學影像技術和微創手術技術的進步，提高了介入性腫瘤治療的精確度和有效性。醫療機構也擴大將這些治療方法納入綜合癌症治療方案中。

隨著研發和技術創新不斷推進，介入腫瘤學市場前景十分光明。透過開發更具針對性的治療方法和改進影像系統，治療效果有望得到提升。隨著醫療系統優先考慮微創手術，介入性腫瘤學將在癌症治療策略中扮演日益重要的角色。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球介入性腫瘤市場：依產品分類

  • 市場分析、洞察與預測
  • 栓塞裝置
  • 消融裝置
  • 輔助設備

第5章 全球介入性腫瘤市場：依手術類型分類

  • 市場分析、洞察與預測
  • 熱消融腫瘤
  • 非熱腫瘤消融
  • 經導管動脈化療栓塞術（TACE）
  • 經導管動脈放射性栓塞術（TARE/SIRT）
  • 經導管動脈栓塞術（TAE）

第6章 全球介入性腫瘤市場：依應用分類

  • 市場分析、洞察與預測
  • 肝癌
  • 肺癌
  • 乳癌
  • 攝護腺癌
  • 腎癌
  • 骨轉移
  • 其他

第7章 全球介入性腫瘤市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 醫院
  • 門診部
  • 研究機構和學術機構

第8章 全球介入性腫瘤市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第10章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Medtronic
    • Boston Scientific Corporation
    • Johnson & Johnson Services
    • Teleflex Incorporated
    • BD（Becton Dickinson & Company）
    • Siemens Healthcare GmbH
    • Terumo Europe NV
    • Merit Medical Systems
    • Cook Medical
    • AngioDynamics
    • Accuray Incorporated
    • IceCure Medical Ltd
    • Profound Medical
    • EDAP TMS
    • Sirtex SIR Spheres Pty Ltd
簡介目錄
Product Code: VMR11212778

The Interventional Oncology Market size is expected to reach USD 4.68 Billion in 2034 from USD 2.46 Billion (2025) growing at a CAGR of 7.4% during 2026-2034.

The global interventional oncology market is expanding rapidly as minimally invasive cancer treatments gain popularity. Interventional oncology involves image-guided procedures that directly target tumors using techniques such as ablation, embolization, and targeted drug delivery. These treatments offer several advantages, including reduced recovery time, minimal surgical risks, and improved patient outcomes.

Several factors are contributing to the growth of this market. The increasing prevalence of cancer worldwide is creating strong demand for effective treatment options. Additionally, advances in medical imaging technologies and minimally invasive surgical techniques are improving the precision and effectiveness of interventional oncology procedures. Healthcare providers are increasingly adopting these treatments as part of comprehensive cancer care programs.

The future outlook for the interventional oncology market appears highly promising as research and technological innovation continue to advance. The development of more targeted therapies and improved imaging systems is expected to enhance treatment outcomes. As healthcare systems prioritize minimally invasive procedures, interventional oncology is likely to become an increasingly important component of cancer treatment strategies.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Embolization Devices
  • Ablation Devices
  • Support Devices

By Procedure

  • Thermal Tumor Ablation
  • Non-Thermal Tumor Ablation
  • Transcatheter Arterial Chemoembolization
  • Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
  • Transcatheter Arterial Embolization/Bland Embolization

By Application

  • Liver Cancer
  • Lung Cancer
  • Breast Cancer
  • Prostate Cancer
  • Kidney Cancer
  • Bone Metastasis
  • Others

By End User

  • Hospital
  • Ambulatory Care Centers
  • Research and Academia

COMPANIES PROFILED

  • Medtronic, Boston Scientific Corporation, Johnson Johnson Services, Teleflex Incorporated, BD Becton Dickinson Company, Siemens Healthcare GmbH, Terumo Europe NV, Merit Medical Systems, Cook Medical, AngioDynamics, Accuray Incorporated, IceCure Medical Ltd, Profound Medical, EDAP TMS, Sirtex SIR Spheres Pty Ltd
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL INTERVENTIONAL ONCOLOGY MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Embolization Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Ablation Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Support Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL INTERVENTIONAL ONCOLOGY MARKET: BY PROCEDURE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Procedure
  • 5.2. Thermal Tumor Ablation Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Non-Thermal Tumor Ablation Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Transcatheter Arterial Chemoembolization Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Transcatheter Arterial Embolization/Bland Embolization Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL INTERVENTIONAL ONCOLOGY MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Application
  • 6.2. Liver Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Lung Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Breast Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Prostate Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.6. Kidney Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.7. Bone Metastasis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL INTERVENTIONAL ONCOLOGY MARKET: BY END USER 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End User
  • 7.2. Hospital Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Ambulatory Care Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Research and Academia Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL INTERVENTIONAL ONCOLOGY MARKET: BY REGION 2022-2034(USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Product
    • 8.2.2 By Procedure
    • 8.2.3 By Application
    • 8.2.4 By End User
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Product
    • 8.3.2 By Procedure
    • 8.3.3 By Application
    • 8.3.4 By End User
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Product
    • 8.4.2 By Procedure
    • 8.4.3 By Application
    • 8.4.4 By End User
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Product
    • 8.5.2 By Procedure
    • 8.5.3 By Application
    • 8.5.4 By End User
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 South East Asia
    • 8.5.10 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Product
    • 8.6.2 By Procedure
    • 8.6.3 By Application
    • 8.6.4 By End User
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL INTERVENTIONAL ONCOLOGY INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Medtronic
    • 10.2.2 Boston Scientific Corporation
    • 10.2.3 Johnson & Johnson Services
    • 10.2.4 Teleflex Incorporated
    • 10.2.5 BD (Becton Dickinson & Company)
    • 10.2.6 Siemens Healthcare GmbH
    • 10.2.7 Terumo Europe NV
    • 10.2.8 Merit Medical Systems
    • 10.2.9 Cook Medical
    • 10.2.10 AngioDynamics
    • 10.2.11 Accuray Incorporated
    • 10.2.12 IceCure Medical Ltd
    • 10.2.13 Profound Medical
    • 10.2.14 EDAP TMS
    • 10.2.15 Sirtex SIR Spheres Pty Ltd